Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A sterile **intravenous crystalloid electrolyte and carbohydrate solution** containing sodium chloride, sodium lactate, calcium chloride, potassium chloride, and dextrose monohydrate. Marketed as **Lactated Ringer's and Dextrose** and described in labeling such as **Lactated Ringer's and 5% Dextrose Injection**, it is used for **fluid and electrolyte replacement**, as an **alkalinizing agent**, and as a **source of water, electrolytes, and calories** in adults and pediatric patients requiring parenteral support. The product does not act through a single discrete molecular target; instead, it systemically expands extracellular fluid volume, supplies sodium, potassium, calcium, chloride, and metabolizable lactate, and provides dextrose calories. It is a marketed hospital infusion product associated with Hospira.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium chloride + sodium lactate + calcium chloride + potassium chloride + dextrose monohydrate.